Cost-effectiveness of pembrolizumab plus chemotherapy for advanced endometrial cancer.

Autor: Gengwei Huo1,2,3,4, Ying Song5, Peng Chen1,2,3,4 chenpengdoc@sina.com
Zdroj: Journal of Gynecologic Oncology. Nov2024, Vol. 35 Issue 6, p1-11. 11p.
Databáze: Academic Search Ultimate